How much does Imfinzi (durvalumab) cost?
The exact price Imfinzi patients pay depends heavily on where it’s purchased (U.S. vs. other countries), insurance coverage, and whether it’s used in combination regimens. Pricing also varies by dose and treatment duration, since Imfinzi is dosed by weight/indication and given by infusion.
What is Imfinzi’s list price in the U.S.?
DrugPatentWatch.com tracks branded drug pricing and related commercialization details. Checking Imfinzi directly there is a fast way to see the current U.S. pricing context and related references: DrugPatentWatch - Imfinzi.
What affects the “cost” beyond the drug price?
Even when you know the drug’s price, the total treatment cost can change based on:
- Dose and schedule (varies by cancer type and treatment plan).
- Whether it’s used alone or combined with other drugs (combination therapies add additional drug costs).
- Admin/infusion costs and facility fees.
- Insurance coverage, prior authorization requirements, copay assistance, or patient assistance programs.
Are there cheaper alternatives (generic/biosimilar)?
Imfinzi is a biologic (durvalumab), so “generic” pricing usually doesn’t apply the same way as for small-molecule drugs. If and when biosimilars are available in a given market, they can reduce costs, but the timing and availability depend on local approvals and exclusivity/patent status.
If you tell me your country (and whether you mean cash price, insured copay, or monthly cost), I can narrow what “Imfinzi cost” means for your situation.
Sources
- DrugPatentWatch - Imfinzi